Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05668117 · ClinicalTrials.gov registry record
RFN-Advanced Retrograde Femoral Nailing System
A clinical trial of Femur Fracture, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 53
- Enrollment target
- 1
- Study location
NCT05668117: Completed study of Femur Fracture, sponsored by University of Alabama at Birmingham.
NCT05668117 is a study of Femur Fracture that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 53 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05668117, a study of Femur Fracture, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a retrospective chart review of the safety and performance Standard of Care data on individuals that have previously been implanted with the femur nail of the RFNA System for the internal fixation of the femur. Demographics, medical history, primary diagnosis, mechanism of injury, type of injury, clinical and radiographic evaluation of bone consolidation, and device-related adverse events were collected. Descriptive statistics were applied to the data collected.
Primary Outcome
Rate of fracture union
Conditions Studied
Interventions
- DEVICE Depuy Synthes Advanced Retrograde femoral nail
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-04-27 |
What the finished NCT05668117 record still lists
NCT05668117 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 1 condition, with Femur Fracture appearing as the primary indexed condition, and to 1 intervention - of which Depuy Synthes Advanced Retrograde femoral nail is the first listed.
NCT05668117 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05668117 about?
NCT05668117 is a clinical study titled "RFN-Advanced Retrograde Femoral Nailing System". This study is a retrospective chart review of the safety and performance Standard of Care data on individuals that have previously been implanted with the femur nail of the RFNA System for the internal fixation of the femur. Demographics, medical history, primary diagnosis, mechanism of injury, type...
What is the current status of trial NCT05668117?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2021-02-01. Estimated completion is 2023-04-27.
What conditions does trial NCT05668117 study?
This clinical trial studies the following conditions: Femur Fracture.
What interventions are being tested in trial NCT05668117?
The interventions under investigation include: Depuy Synthes Advanced Retrograde femoral nail (DEVICE).
Who is sponsoring clinical trial NCT05668117?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05668117 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femur Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI